510(k) Report

510(k) · Cleared

Cleared

Biotres

K211709510(k) TraditionalCleared Jan 19, 2022230-day reviewClass II21 CFR 870.2800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biotricity · MWJ Electrocardiograph, Ambulatory (Without Analysis)

Cleared on Jan 19, 2022 as substantially equivalent to K171410 (Braemar Manufacturing, LLC, 2018) after a 230-day review. Its family tree reaches back 6 generations to 1996. 2 later devices descend from it.

Decided
Jan 19, 2022
Review
230 days
Class
Class II
Product code
MWJ
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K950944 (1996). 8 ancestors in all. 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2012: 1 other ancestor2009: 1 other ancestor2022: 1 descendant cleared2024: 1 descendant clearedK950944 · Ambulatory (Holter) Recording System · Biosensor Corp. · 1996K993618 · DXP1000 Holter Recorder · Braemar Corp. · 1999K113176 · Mysense Heart · Cardiac Science Corporation · 2011K131190 · Mypatch · Dms-Service, LLC · 2013K160704 · myPatch-s · Dms-Service, LLC · 2016K171410 · ePatch · Braemar Manufacturing, LLC · 20181995200020052010201520202025
  1. Root · 6 generations backK950944 Ambulatory (Holter) Recording SystemBiosensor Corp. · 1996
  2. 5 generations backK993618 DXP1000 Holter RecorderBraemar Corp. · 1999
  3. 4 generations backK113176 Mysense HeartCardiac Science Corporation · 2011
  4. 3 generations backK131190 MypatchDms-Service, LLC · 2013
  5. 2 generations backK160704 myPatch-sDms-Service, LLC · 2016
  6. 1 generation backK171410 ePatchBraemar Manufacturing, LLC · 2018
  7. This deviceK211709 BiotresBiotricity · 2022
  8. Descendant · cites it directly · 0 of its ownK233864 ASSURE Wearable ECGKestra Medical Technologies, Inc. · 2024
  9. Descendant · cites it directly · 0 of its ownK222017 BiotresBiotricity · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K233864ASSURE Wearable ECGKestra Medical Technologies, Inc. · 2024 · cites it directly0descendants
  • K222017BiotresBiotricity · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K950944Ambulatory (Holter) Recording SystemBiosensor Corp.1996—
−5K993618DXP1000 Holter RecorderBraemar Corp.1999—
−4K113176Mysense HeartCardiac Science Corporation2011—
−3K131190MypatchDms-Service, LLC2013—
−2K160704myPatch-sDms-Service, LLC2016—
−1K171410ePatchBraemar Manufacturing, LLC2018—
0 (this device)K211709BiotresBiotricity2022—
+1K233864ASSURE Wearable ECGKestra Medical Technologies, Inc.2024—
+1K222017BiotresBiotricity2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200910
201210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202410
FIG. 1 — Lineage of K211709, 1996–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MWJ device

  1. #1 K254119 Wearable ECG Recorder (YMHeart XY-12)…score 14.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K171410ePatch
Summary page 4
…h, Ambulatory (without Analysis) III. PREDICATE DEVICE The ePatch (Braemar Manufacturing, LLC) was cleared under K171410. Name of Device: ePatch Classification Regulation: 21 CFR§870.2800 Common Name:…
Braemar Manufacturing, LLC2018—

Also cleared against K171410: 2 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K233864ASSURE Wearable ECGKestra Medical Technologies, Inc.20240
K222017BiotresBiotricity20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 6 companies; a new generation was cleared every 3.4 years on median.
  • None of the 8 ancestors has a recall.
  • Of its descendants, K233864 (Kestra Medical Technologies, Inc., 2024) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K171410.

How does its category compare?

All MWJ devices

MWJ Electrocardiograph, Ambulatory (Without Analysis): FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · MWJ

2in 2024

2007: 52008: 12009: 22010: 32011: 32012: 12013: 32014: 22016: 22018: 12021: 12022: 42024: 22026 (partial year): 5
2007high 5 (2007) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MWJ

337in 2022

2007: 142 days median2010: 90 days median2011: 206 days median2013: 241 days median2022: 337 days median2026 (partial year): 270 days median
2007high 337 (2022) · low 90 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MWJ

2in 2024

2024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MWJ

8in 2025

2009: 52012: 22013: 42014: 12015: 12016: 12017: 22018: 12019: 42020: 122021: 32022: 62023: 52024: 32025: 8
2007high 12 (2020) · low 0 (2007)2025

MAUDE reports naming product code MWJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007514200
20081—00
20092—05
201039000
2011320600
20121—02
2013324104
20142—01
20150—01
20162—01
20170—02
20181—01
20190—04
20200—012
20211—03
2022433706
20230—05
20242—23
20250—08
202652700—

What is it indicated for?

The Biotres is indicated for use on adult patients 18 years or older who may be asymptomatic or who suffer from transient symptoms such as palpitations, shortness of breath, dizziness, light headedness, pre-syncope, syncope, fatigue, chest pain and/or anxiety and may require cardiac recording on a continuous basis for up to 30 days. The signal acquired by the Biotres is not intended and should not be used for automated or semi-automated analysis.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K211709: Biotres.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211709

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026